At meeting held on 30 May 2015
Span Diagnostics announced that the Board of Directors of the Company at its meeting held on 30 May 2015, inter alia, have considered and approve buyback of equity shares of the face value of Rs. 10 each of the Company not exceeding 25% of the paid up share capital at a price of Rs. 65/- per Equity Share through the "Tender Offer" route as prescribed under the Securities and Exchange Board of India (Buy Back of Securities), Regulations, 1998 as amended (the Buyback Regulations") subject to the approval of shareholders by way of Special Resolutions through postal ballot and such regulatory compliances as required under the law including provisions of the Company Act, 2013 and rules made thereunder.Powered by Capital Market - Live News